Huntington National Bank’s VIROPHARMA INC VPHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50 | Hold |
1
| – | – | ﹤0.01% | 2910 |
|
|
2025
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 2824 |
|
|
2025
Q3 | $50 | Hold |
1
| – | – | ﹤0.01% | 2904 |
|
|
2025
Q2 | $50 | Hold |
1
| – | – | ﹤0.01% | 2938 |
|
|
2025
Q1 | $50 | Hold |
1
| – | – | ﹤0.01% | 2971 |
|
|
2024
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 2999 |
|
|
2024
Q3 | $50 | Hold |
1
| – | – | ﹤0.01% | 2991 |
|
|
2024
Q2 | $50 | Hold |
1
| – | – | ﹤0.01% | 2952 |
|
|
2024
Q1 | $50 | Hold |
1
| – | – | ﹤0.01% | 2792 |
|
|
2023
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 2691 |
|
|
2023
Q3 | $50 | Hold |
1
| – | – | ﹤0.01% | 2673 |
|
|
2023
Q2 | $50 | Hold |
1
| – | – | ﹤0.01% | 2646 |
|
|
2023
Q1 | $50 | Hold |
1
| – | – | ﹤0.01% | 2488 |
|
|
2022
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 2341 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2774 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2777 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2704 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2630 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2356 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2245 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2134 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2112 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2058 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2071 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2166 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2178 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2084 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2118 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 2112 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2170 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2157 |
|
Huntington National Bank's VPHM Position: Q1 2026 in Review
Huntington National Bank held its VIROPHARMA INC (VPHM) position steady in Q1 2026 at 1 share worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #2910.
Huntington National Bank first reported a position in VPHM in Q3 2018 and has held it in 30 quarters since. 1 fund tracked by Wall St. Rank holds VPHM as of Q1 2026.
- Huntington National Bank held 1 share of VIROPHARMA INC worth $50 as of Q1 2026.
- Huntington National Bank left its VIROPHARMA INC share count unchanged in Q1 2026.
- VIROPHARMA INC made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2910 holding.
- Huntington National Bank first reported a position in VIROPHARMA INC in Q3 2018 and has held it in 30 quarters since.
- 1 fund tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.